found that SNHG6‐003 modulates the expression of transforming growth factor‐β‐activated kinase 1 (TAK1), and the upregulation of SNHG6‐003 and TAK1 correlates with tumor progression in human cancers. The gene discussed is SNHG6; the disease is neoplasm.